Shares of Cerner Corporation CERN were trading lower by more than 1 percent on Monday after the company's CEO disclosed in a letter to clients, shareholders and colleagues he has been diagnosed with a soft tissue cancer.
Cerner's CEO, Neal Patterson, said in a letter he was diagnosed with cancer just after the new year and his physician says the cancer is treatable and curable.
Patterson added there is no evidence of the cancer spreading elsewhere in the body and he will begin treatment immediately.
"We have the best leadership team in health care IT, and we are well equipped to continue to manage Cerner with our existing leadership structure while I receive treatment," Patterson said in his letter. "I plan to stay involved in the business, but with less travel and fewer meetings. In reality, it will not be a big change compared to how we run Cerner day to day already."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
